These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28759482)

  • 21. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study.
    Hoyt MR; Shah U; Cooley J; Temple M
    Int J Obstet Anesth; 2018 May; 34():67-72. PubMed ID: 29486974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment.
    Moore BA; Fiellin DA; Cutter CJ; Buono FD; Barry DT; Fiellin LE; O'Connor PG; Schottenfeld RS
    J Subst Abuse Treat; 2016 Dec; 71():54-57. PubMed ID: 27776678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
    Ling W; Casadonte P; Bigelow G; Kampman KM; Patkar A; Bailey GL; Rosenthal RN; Beebe KL
    JAMA; 2010 Oct; 304(14):1576-83. PubMed ID: 20940383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.
    Murphy SM; Dweik D; McPherson S; Roll JM
    Am J Drug Alcohol Abuse; 2015 Jan; 41(1):88-92. PubMed ID: 25490610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.
    Walsh SL; Nuzzo PA; Babalonis S; Casselton V; Lofwall MR
    Drug Alcohol Depend; 2016 May; 162():190-8. PubMed ID: 27012435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).
    Kunøe N; Opheim A; Solli KK; Gaulen Z; Sharma-Haase K; Latif ZE; Tanum L
    BMC Pharmacol Toxicol; 2016 Apr; 17(1):18. PubMed ID: 27121539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buprenorphine/naloxone in opioid-dependent humans.
    Stoller KB; Bigelow GE; Walsh SL; Strain EC
    Psychopharmacology (Berl); 2001 Mar; 154(3):230-42. PubMed ID: 11351930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
    McDermott KA; Griffin ML; Connery HS; Hilario EY; Fiellin DA; Fitzmaurice GM; Weiss RD
    J Clin Psychiatry; 2015 Feb; 76(2):189-94. PubMed ID: 25562462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans.
    Amass L; Bickel WK; Crean JP; Blake J; Higgins ST
    Psychopharmacology (Berl); 1998 Apr; 136(3):217-25. PubMed ID: 9566806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
    Marsch LA; Bickel WK; Badger GJ; Jacobs EA
    Drug Alcohol Depend; 2005 Feb; 77(2):195-204. PubMed ID: 15664721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction.
    Ghodse H; Myles J; Smith SE
    Br J Psychiatry; 1994 Sep; 165(3):370-4. PubMed ID: 7994508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three methods of opioid detoxification in a primary care setting. A randomized trial.
    O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ
    Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.
    Zheng W; Nickasch M; Lander L; Wen S; Xiao M; Marshalek P; Dix E; Sullivan C
    J Addict Med; 2017; 11(2):138-144. PubMed ID: 28107210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling.
    Kornør H; Waal H; Ali RL
    Drug Alcohol Rev; 2006 Mar; 25(2):123-30. PubMed ID: 16627301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Buprenorphine as opioid substitution to pregnant addicts].
    Rasmussen ET; Nielsen LB
    Ugeskr Laeger; 2003 Sep; 165(38):3607-8. PubMed ID: 14556390
    [No Abstract]   [Full Text] [Related]  

  • 39. Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
    Lofwall MR; Walsh SL; Nunes EV; Bailey GL; Sigmon SC; Kampman KM; Frost M; Tiberg F; Linden M; Sheldon B; Oosman S; Peterson S; Chen M; Kim S
    JAMA Intern Med; 2018 Jun; 178(6):764-773. PubMed ID: 29799968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.